ONCOTICE 5 hundred million CFU powder for injection vial 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

oncotice 5 hundred million cfu powder for injection vial

merck sharp & dohme (australia) pty ltd - mycobacterium bovis (bacillus calmette and guerin (bcg) strain), quantity: 200000000 cfu - injection, powder for - excipient ingredients: citric acid monohydrate; ferric ammonium citrate; strong ammonia solution; purified water; asparagine; magnesium sulfate heptahydrate; zinc formate dihydrate; lactose monohydrate; dibasic potassium phosphate; glycerol - onco tice is used as a treatment of primary or recurrent carcinomain situ of the urinary bladder. onco tice is also used after transurethral resection for the prevention or recurrence of high grade and/or relapsing superficial papillary transitional cell carcinoma of the urinary bladder (viz papillary carcinoma stage ta or t1 - grades 1, 2, or 3) indications as at 3 october 2001: oncotice is used as a treatment ofthe urinary bladder. oncotice is also used after transurethral resection for the prevention of recurrence of high grade and/or relapsing superficial papillary transitional cell carinoma of the urinary bladder (viz papillary carcinoma stage ta (grade 2 or 3) or t1 (grade 1, 2, or 3). oncotice is only recommended for stage ta grade 1 tumours, when there is judged to be a high risk of tumour recurrence is considered likely. inidications as at 24 april 2002: oncotice is used as a treatment of primary of recurrent carcinoma in situ (cid) of the urinary bladder. oncotice is also used after transurethral resection for the prevention of recurrence of high grade and/or relapsing superficial papillary transitional cell carcinoma of the urinary bladder (viz papillary carcinoma stage ta (grade 2 or 3) or t1 (grade 1, 2, or 3). oncotice is only reccommended for stage ta grade 1 tumours, when there is judged to be a high risk of tumour recurrence.

CALMETTES NITE 125 MG 津巴布韦 - 英文 - Medicines Control Authority

calmettes nite 125 mg

abbott laboratories sa (pty) ltd - valerian - tablet; oral - 125mg

CALMETTES NITE 45 MG 津巴布韦 - 英文 - Medicines Control Authority

calmettes nite 45 mg

abbott laboratories sa (pty) ltd - valerian - tablet; oral - 45mg

CALMETTES Tablets 125 mg 坦桑尼亚 - 英文 - Tanzania Medicinces & Medical Devices Authority

calmettes tablets 125 mg

abbott laboratories s.a (pty) ltd., south africa - valerian hydroalcoholic extract - tablets - 125 mg

Calmettes Nite Tablets 45 mg 坦桑尼亚 - 英文 - Tanzania Medicinces & Medical Devices Authority

calmettes nite tablets 45 mg

abbott laboratories s.a (pty) ltd., south africa - valerian hydroalcoholic extract - tablets - 45 mg

Calmettes Nite Tablets 125 mg 坦桑尼亚 - 英文 - Tanzania Medicinces & Medical Devices Authority

calmettes nite tablets 125 mg

abbott laboratories s.a (pty) ltd., south africa - valerian hydroalcoholic extract - tablets - 125 mg

CALMETTES TABLET 南非 - 英文 - South African Health Products Regulatory Authority (SAHPRA)

calmettes tablet

abbott laboratories s.a. (pty) ltd - tablet - 45,0 mg - each tablet contains valerian 45 mg

Calmettes Tablets 纳米比亚 - 英文 - Namibia Medicines Regulatory Council

calmettes tablets

abbott laboratories sa (pty) ltd - valerian dispert powder of natural origin - tablets - each tablet contains valerian dispert powder of natural origin 45mg

Calmettes Forte Tablets 纳米比亚 - 英文 - Namibia Medicines Regulatory Council

calmettes forte tablets

abbott laboratories sa (pty) ltd - valerian dispert powder of natural origin - tablets - each tablet contains valerian dispert powder of natural origin 125mg

ONCOTICE POWDER FOR SOLUTION 加拿大 - 英文 - Health Canada

oncotice powder for solution

merck canada inc - bacillus calmette-guerin (bcg) strain tice - powder for solution - 800000000unit - bacillus calmette-guerin (bcg) strain tice 800000000unit - vaccines